(Q47852039)

6 February 2018

title

Increased FDG uptake in breast cancer is associated with prognostic factors. (English)

1 reference

6 February 2018

author name string

Yasemin Sanli

1

1 reference

6 February 2018

Serkan Kuyumcu

2

1 reference

6 February 2018

Zeynep Gozde Ozkan

3

1 reference

6 February 2018

Göknur Işik

4

1 reference

6 February 2018

Hasan Karanlik

5

1 reference

6 February 2018

Burcu Guzelbey

6

1 reference

6 February 2018

Cuneyt Turkmen

7

1 reference

6 February 2018

Sevda Ozel

8

1 reference

6 February 2018

Ekrem Yavuz

9

1 reference

6 February 2018

Ayse Mudun

10

1 reference

6 February 2018

publication date

24 February 2012

1 reference

6 February 2018

Annals of Nuclear Medicine

published in

1 reference

6 February 2018

volume

26

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

345-350

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s12149-012-0579-2

exact match

0 references

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Staging of breast cancer with ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Is there a role for positron emission tomography in breast cancer staging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0579-2

10.1007/S12149-012-0579-2

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

22359222

1 reference

6 February 2018